TraceLink Wins 2024 Merit Award for Technology in HealthTech Category for Second Consecutive Year

January 15, 2025 03:42 AM AEDT | By Cision

TraceLink Wins 2024 Merit Award for Technology in HealthTech Category for Second Consecutive Year — Image source: Kalkine Media

Recent News

ASX Sees Gains with Copper and Iron Ore Surge, Lithium Miners Lead the...

Is Aristocrat Leisure (ASX:ALL) at Risk of Underperforming?

Yandal Resources (ASX:YRL) Unveils New Gold Prospect in Western Austra...

Reece Limited (ASX:REH) Appoints Vulcan Steel's CCO as Non-Executive D...

BOSTON, Jan. 15, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, is proud to announce its recognition as a winner of the 2024 Merit Awards for Technology in the HealthTech category. This marks the second consecutive year that TraceLink has been honored for its innovation and excellence in leveraging technology to transform healthcare.

TraceLink was founded with a mission to revolutionize the healthcare supply chain by leveraging the power of a digital network platform that now links over 291,000 healthcare and life sciences entities worldwide. This year, we took a significant leap forward with OPUS, the Orchestration Platform for Universal Solutions, delivering groundbreaking innovations that redefine how the Life Sciences and Healthcare industry collaborates and adapts to challenges. By enabling seamless data exchange, predictive insights, and intelligent orchestration across the supply chain, OPUS has empowered organizations to mitigate risks, optimize operations, and ensure critical medical products reach patients faster and more reliably. This honor highlights our relentless pursuit of transforming the future of healthcare through innovation and collaboration.

"This recognition underscores the impact of our platform and solutions in addressing critical challenges in healthcare, from supply chain disruptions to patient safety," said Shabbir Dahod, President and CEO of TraceLink. "Our team remains committed to pioneering innovations that drive resilience, efficiency, and better outcomes across the global healthcare supply chain."

The Merit Awards, an independent program recognizing excellence across global industries, celebrates the best in current and next-generation innovations and technologies. This year's winners were lauded for their visionary contributions and commitment to setting new standards of technological excellence.

"Healthcare is a critical part of our lives, whether business or personal," said Marie Zander, executive director, Merit Awards. "We were thrilled to receive the submissions that spoke to the services, products, innovations, and technologies that are shaping the healthcare marketplace. Congratulations to all of this year's winners."

The 2024 Merit Award adds to a growing list of accolades for TraceLink's role in shaping the future of healthcare technology. For the full list of 2024 Merit Awards for Technology winners, visit Merit Awards Winners.

To learn more about TraceLink's OPUS platform and suite of end-to-end orchestration capabilities for External Manufacturing, Procurement, Logistics, Commerce, Quality, Clinical, and more, leverage TraceLink's AI-powered assistant, Amadeus, at https://www.tracelink.com/resources/tracelink-university.

About TraceLink
TraceLink Inc. is the largest end-to-end intelligent supply chain platform for life sciences and healthcare, enabling end-to-end orchestration by connecting more than 291,000 healthcare and life sciences entities through its B2N Integrate-Once™ network. Leading businesses trust TraceLink to deliver complete global connectivity, visibility, and traceability of healthcare products, ensuring that every patient gets the medicines they need when needed, safely and securely.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Full Name

Mobile

By submitting your details above and clicking on the 'Download Report' button, you confirm that you are happy for one of the representatives of Kalkine Media or its group entities to contact you to discuss the services, consent to - our Terms & Conditions, and to receive marketing offers, including to be contacted by email or phone, as set out in our Privacy Policy. Any calls will be made by Kalkine group's telemarketing entities on our behalf or on behalf of Kalkine group entities.

Markets

Disclaimer

Recent Articles

1

2

3

4

5

Investing Tips

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27